Skip to content

RNTX RNTX Retained Earnings

Retained Earnings at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$18.29B+13.5%
Gilead Sciences logo
Gilead SciencesGILD
$14.13B+29.3%
AbbVie logo
AbbVieABBV
-$17.87B-87.6%
CTO
Citius Oncology, Inc.CTOR
-$96.18M-79.2%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$616.96M-12.8%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-$77.67M-9.8%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's retained earnings?
RNTX (RNTX) reported retained earnings of -$407.11M in Q1 2026.
How has RNTX's retained earnings changed year-over-year?
RNTX's retained earnings decreased by 14.1% year-over-year, from -$356.9M to -$407.11M.
What is the long-term trend for RNTX's retained earnings?
Over 5 years (2020 to 2025), RNTX's retained earnings has grown at a 12.8% compound annual growth rate (CAGR), from -$219.29M to -$401.27M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.